Literature DB >> 27739021

Surgical Treatment of Parkinson's Disease.

Leo Verhagen Metman1, Gian Pal2, Konstantin Slavin3.   

Abstract

OPINION STATEMENT: Deep brain stimulation is now an established therapy for Parkinson's disease, and DBS continues to be refined. Well-established targets, such as the STN and GPi, have shown clear benefit in reducing motor complications in PD, and other more novel targets, such as PPN are being explored. Furthermore, there have been advances in imaging which allow for improved lead placement and also can reduce patient discomfort. The way electrical current is delivered through the DBS lead is also undergoing a transformation, allowing for more options regarding current shaping, steering, and new stimulation paradigms. The future holds promise for novel methodologies of neuromodulation including closed-loop devices and more focused lesion therapies that alter CNS circuitry.

Entities:  

Keywords:  Closed loop; Current steering; DBS; Focused ultrasound; Intraoperative imaging; Stereotactic surgery

Year:  2016        PMID: 27739021     DOI: 10.1007/s11940-016-0432-3

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  62 in total

1.  Interleaving deep brain stimulation for a patient with both Parkinson's disease and essential tremor.

Authors:  Christian R Baumann; Lukas L Imbach; Heide Baumann-Vogel; Mechtild Uhl; Johannes Sarnthein; Oguzkan Sürücü
Journal:  Mov Disord       Date:  2012-10-31       Impact factor: 10.338

2.  Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.

Authors:  Yi Liu; Weina Li; Changhong Tan; Xi Liu; Xin Wang; Yuejiang Gui; Lu Qin; Fen Deng; Changlin Hu; Lifen Chen
Journal:  J Neurosurg       Date:  2014-06-06       Impact factor: 5.115

Review 3.  Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations.

Authors:  Alberto Priori; Guglielmo Foffani; Lorenzo Rossi; Sara Marceglia
Journal:  Exp Neurol       Date:  2012-09-27       Impact factor: 5.330

4.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

5.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Authors:  Valerie C Anderson; Kim J Burchiel; Penelope Hogarth; Jacques Favre; John P Hammerstad
Journal:  Arch Neurol       Date:  2005-04

6.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

7.  Neurostimulation for Parkinson's disease with early motor complications.

Authors:  W M M Schuepbach; J Rau; K Knudsen; J Volkmann; P Krack; L Timmermann; T D Hälbig; H Hesekamp; S M Navarro; N Meier; D Falk; M Mehdorn; S Paschen; M Maarouf; M T Barbe; G R Fink; A Kupsch; D Gruber; G-H Schneider; E Seigneuret; A Kistner; P Chaynes; F Ory-Magne; C Brefel Courbon; J Vesper; A Schnitzler; L Wojtecki; J-L Houeto; B Bataille; D Maltête; P Damier; S Raoul; F Sixel-Doering; D Hellwig; A Gharabaghi; R Krüger; M O Pinsker; F Amtage; J-M Régis; T Witjas; S Thobois; P Mertens; M Kloss; A Hartmann; W H Oertel; B Post; H Speelman; Y Agid; C Schade-Brittinger; G Deuschl
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

8.  GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.

Authors:  Vincent J J Odekerken; Judith A Boel; Ben A Schmand; Rob J de Haan; M Figee; Pepijn van den Munckhof; P Richard Schuurman; Rob M A de Bie
Journal:  Neurology       Date:  2016-01-27       Impact factor: 9.910

9.  Deep brain stimulation for Parkinson's disease using frameless technology.

Authors:  Chun-Yuan Cheng; Ming-Tai Hsing; Yung-Hsiang Chen; Sey-Lin Wu; Hiu Ngar Sy; Chien-Min Chen; Yu-Jen Yang; Meng-Chih Lee
Journal:  Br J Neurosurg       Date:  2013-10-18       Impact factor: 1.596

10.  A pilot study of focused ultrasound thalamotomy for essential tremor.

Authors:  W Jeffrey Elias; Diane Huss; Tiffini Voss; Johanna Loomba; Mohamad Khaled; Eyal Zadicario; Robert C Frysinger; Scott A Sperling; Scott Wylie; Stephen J Monteith; Jason Druzgal; Binit B Shah; Madaline Harrison; Max Wintermark
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

View more
  7 in total

1.  Deep Brain Stimulation at End of Life: Clinical and Ethical Considerations.

Authors:  Lauren R Sankary; Paul J Ford; Andre G Machado; Laura J Hoeksema; Renato V Samala; David J Harris
Journal:  J Palliat Med       Date:  2019-08-12       Impact factor: 2.947

Review 2.  Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Authors:  Leonardo Almeida; Wissam Deeb; Chauncey Spears; Enrico Opri; Rene Molina; Daniel Martinez-Ramirez; Aysegul Gunduz; Christopher W Hess; Michael S Okun
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 3.  Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.

Authors:  Kevin M Budge; Matthew L Neal; Jason R Richardson; Fayez F Safadi
Journal:  Mol Neurobiol       Date:  2017-08-30       Impact factor: 5.590

Review 4.  The role of deep brain stimulation in Parkinson's disease: an overview and update on new developments.

Authors:  John Y Fang; Christopher Tolleson
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-07       Impact factor: 2.570

5.  Altered emotional prosody processing in patients with Parkinson's disease after subthalamic nucleus stimulation.

Authors:  Yazhou Jin; Zhiqi Mao; Zhipei Ling; Xin Xu; Guang Xie; Xinguang Yu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-12-11       Impact factor: 2.570

Review 6.  Current Experimental Studies of Gene Therapy in Parkinson's Disease.

Authors:  Jing-Ya Lin; Cheng-Long Xie; Su-Fang Zhang; Weien Yuan; Zhen-Guo Liu
Journal:  Front Aging Neurosci       Date:  2017-05-03       Impact factor: 5.750

Review 7.  Gene Therapy for Parkinson's Disease, An Update.

Authors:  Tobias M Axelsen; David P D Woldbye
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.